This site needs JavaScript to work properly. Please enable it to take advantage of the complete set of features!

Skip to main page content

Add to Collections

Your saved search

Name of saved search:

Search terms:

Test search terms

Would you like email updates of new search results?

Yes
No

Email: (change)

Frequency:

Which day?

Which day?

Report format:

Send at most:

Send even when there aren't any new results

Optional text in email:

Your RSS Feed

. 1979 Feb 28;86(4):1051-7.

doi: 10.1016/0006-291x(79)90223-7.

Interaction of antitumor drugs with human erythrocyte ghost membranes and mastocytoma P815: a spin label study

B K Sinha, C F Chignell

PMID: 435309
DOI: 10.1016/0006-291x(79)90223-7

Interaction of antitumor drugs with human erythrocyte ghost membranes and mastocytoma P815: a spin label study

B K Sinha et al. Biochem Biophys Res Commun. 1979.

. 1979 Feb 28;86(4):1051-7.

doi: 10.1016/0006-291x(79)90223-7.

Authors

B K Sinha, C F Chignell

PMID: 435309
DOI: 10.1016/0006-291x(79)90223-7

No abstract available

PubMed Disclaimer

Similar articles

Spin-label study of phenothiazine interactions with erythrocyte ghost membranes: a possible membrane-mediated antisickling action.
Jones GL, Woodbury DM. Jones GL, et al. J Pharmacol Exp Ther. 1978 Oct;207(1):203-11. J Pharmacol Exp Ther. 1978. PMID: 702341
Spin label study of phenothiazine interactions with the lipid phase of erythrocyte membranes.
Jones GL. Jones GL. Proc West Pharmacol Soc. 1980;23:399-404. Proc West Pharmacol Soc. 1980. PMID: 6250157 No abstract available.
A spin label study of human erythrocyte ghost membranes damaged by methyl phenyldiazenecarboxylate (azoester).
Chignell CF, Starkweather DK. Chignell CF, et al. Life Sci. 1974 Feb 16;14(4):641-52. doi: 10.1016/0024-3205(74)90446-9. Life Sci. 1974. PMID: 4363007 No abstract available.
Cell membranes as target for anticancer agents.
Arancia G, Donelli G. Arancia G, et al. Pharmacol Res. 1991 Oct;24(3):205-17. doi: 10.1016/1043-6618(91)90083-a. Pharmacol Res. 1991. PMID: 1956865 Review. No abstract available.
Membranes and cancer chemotherapy.
Burns CP. Burns CP. Cancer Invest. 1988;6(4):439-51. doi: 10.3109/07357908809080073. Cancer Invest. 1988. PMID: 3052704 Review. No abstract available.

See all similar articles

Cited by

Interaction of the antitumour drug 4'-(9-acridinylamino)-methanesulfon-m-anisidine.HCl (m-AMSA) with nucleic acids.
Hudecz F, Kajtár J, Szekerke M. Hudecz F, et al. Nucleic Acids Res. 1981 Dec 21;9(24):6959-73. doi: 10.1093/nar/9.24.6959. Nucleic Acids Res. 1981. PMID: 6174949 Free PMC article.
Flicker spectroscopy of erythrocytes. A sensitive method to study subtle changes of membrane bending stiffness.
Fricke K, Wirthensohn K, Laxhuber R, Sackmann E. Fricke K, et al. Eur Biophys J. 1986;14(2):67-81. doi: 10.1007/BF00263063. Eur Biophys J. 1986. PMID: 3816703
Enhanced susceptibility of target KMT-17 cells to activated macrophages by treatment with the antitumor agent bleomycin.
Xu ZY, Hosokawa M, Morikawa K, Kobayashi H. Xu ZY, et al. Cancer Immunol Immunother. 1986;23(1):46-50. doi: 10.1007/BF00205554. Cancer Immunol Immunother. 1986. PMID: 2429768 Free PMC article.
Cancer chemotherapeutics as immunomodulators.
Spreafico F, Vecchi A, Colotta F, Montovani A. Spreafico F, et al. Springer Semin Immunopathol. 1985;8(4):361-74. doi: 10.1007/BF01857390. Springer Semin Immunopathol. 1985. PMID: 2935958 No abstract available.

MeSH terms

Actions
Actions
Actions
Actions
Actions
Actions
Actions
Actions
Actions
Actions

Substances

Actions
Actions

LinkOut - more resources

Full Text Sources
- Elsevier Science